Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

15 further concessionary prices announced for May

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 15 items for May 2019 prescriptions.

An initial 27 prices for the month were announced yesterday (May 23).

Drug
Strength
Form
Price
Bumetanide
1mg
tablets (28)
£1.85
Chloramphenicol
0.5%
eye drops (10ml)
£2.16
Clomipramine
50mg
capsules (28)
£4.12
Diamorphine
30mg
powder for solution for injection ampoules (5)
£16.52
Dosulepin
75mg
tablets (28)
£12.59
Losartan
12.5mg
tablets (28)
£4.62
Metoprolol
50mg
tablets (28)
£6.23
Metronidazole
400mg
tablets (21)
£6.00
Pantoprazole
20mg
gastro-resistant tablets (28)
£4.25
Pantoprazole
40mg
gastro-resistant tablets (28)
£6.95
Quinine bisulfate
300mg
tablets (28)
£2.38
Quinine sulfate
300mg
tablets (28)
£3.79
Risedronate sodium
35mg
tablets (4)
£11.60
Tibolone
2.5mg
tablets (28)
£9.00
Topiramate
100mg
tablets (60)
£21.83

Do these prices reflect the ones you have paid for May so far?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD005906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel